DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodial…
What to know about DVA
DaVita Inc. is a large Healthcare company with a mixed financial profile. It scores well on valuation and dividends, but sentiment is worth keeping an eye on.
Should you consider DVA?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
DaVita Inc. is a large-cap Healthcare company with a mixed overall financial profile — it ranks near the bottom of Healthcare stocks (56 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
Analyst sentiment is cautious and short interest is relatively elevated — meaning some professional investors are actively betting the price will fall. Worth understanding why.
-
There are several areas of concern. This may suit investors with a higher risk tolerance or a specific contrarian view on the Healthcare sector.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how DVA compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 20.01 | Above avg |
| Forward P/E | 12.10 | Above avg |
| PEG Ratio | 0.65 | Top 25% |
| Price to Sales | 0.96 | Top 25% |
| Price to Book | -18.21 | Top 25% |
| EV/EBITDA | 9.95 | Top 25% |
| Earnings Yield | 5.00% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 32.45% | Average |
| Operating Margin | 13.86% | Average |
| Net Profit Margin | 5.65% | Below avg |
| Return on Equity | 80.98% | Top 25% |
| Return on Invested Capital | 7.50% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 6.00% | Average |
| Revenue Growth (3Y CAGR) | 5.53% | Above avg |
| EPS Growth (YoY) | 43.50% | Above avg |
| Free Cash Flow Growth | -10.63% | Average |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.42 | Above avg |
| Debt to Equity | 12.61 | Below avg |
| Interest Coverage | 3.32 | Below avg |
| Altman Z-Score | 1.67 | Below avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | 0.00% | Top 25% |
| Dividend Growth (5Y) | — | N/A |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 11.19% | Top 25% |
| OCF to Sales | 14.65% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.91 | Above avg |
| Volatility (30-Day) | 27.53% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 14.79% | Below avg |
| Avg. Analyst Rating | 2.75 | Below avg |
| Target Upside % | -6.83% | Below avg |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 13.34B | Below avg |
How does DVA compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to DVA — based on their financial profile.